7月23日，丹纳赫盘中上涨4.25%，报186.49美元/股，成交额9644.25万美元，在此前连续两个交易日累计下跌约20%后出现修复性反弹。
消息面上，公司7月21日发布Q2财报，非GAAP每股收益1.94美元、营收62.65亿美元均超预期，但Q3核心收入增速仅指引2.0%-3.0%，显著低于Q2表现，引发连续两日急跌。财报后Morgan Stanley将目标价由255美元降至220美元，Evercore ISI由230美元降至205美元，但均维持买入评级，当前机构均价目标227.50美元显著高于现价，为超跌反弹提供估值支撑。此外，生命科学工具和服务行业今日整体表现强势，赛默飞世尔涨9.39%、艾昆纬涨6.42%，板块联动亦助推反弹动能。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.